au.\*:("LEUCUTA S")
Results 1 to 25 of 26
Selection :
ETUDE PHYSICO-CHIMIQUE DE L'INTERACTION DU DIAZEPAM AVEC DES EXCIPIENTS HYDROPHILESNEAMTU M; LEUCUTA S.1980; ANN. PHARM. ER.; ISSN 0003-4509; FRA; DA. 1980 PUBL. 1981; VOL. 38; NO 6; PP. 507-511; ABS. ENG; BIBL. 7 REF.Article
ETUDE PHYSICO-CHIMIQUE DES DISPERSIONS SOLIDES HYDROPHILES DU PHENOBARBITALLEUCUTA S; NEAMTU M.1980; ANN. PHARM. FR.; ISSN 0003-4509; FRA; DA. 1980 PUBL. 1981; VOL. 38; NO 5; PP. 411-420; ABS. ENG; BIBL. 14 REF.Article
The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpineLEUCUTA, S. E.International journal of pharmaceutics. 1989, Vol 54, Num 1, pp 71-78, issn 0378-5173Article
The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in manLEUCUTA, S. E.Pharmazie. 1988, Vol 43, Num 12, pp 845-848, issn 0031-7144Article
Controlled release of nifedipine from gelatin microspheres and microcapsules : in vitro kinetics and pharmacokinetics in manLEUCUTA, S. E.Journal of microencapsulation. 1990, Vol 7, Num 2, pp 209-217, issn 0265-2048Article
ETUDE PHYSICOCHIMIQUE DE L'INTERACTION ENTRE LE LAURYL SULFATE DE SODIUM ET QUELQUES ANTIBIOTIQUESLEUCUTA S; SCHWARTZ I; POPOVICI A et al.1976; FARMACIA; ROMAN.; DA. 1976; VOL. 24; NO 1; PP. 47-54; ABS. ANGL. RUSSE; BIBL. 21 REF.Article
Use of experimental design for identifying the most important formulation and technological variables in pelletization by powder layeringTOMUTA, I; LEUCUTA, S. E.STP pharma sciences. 2004, Vol 14, Num 3, pp 215-221, issn 1157-1489, 7 p.Article
The influence of formulation factors on the kinetic release of metoprolol tartrate from prolong release coated minitabletsTOMUTA, Ioan; LEUCUTA, S. E.Drug development and industrial pharmacy. 2007, Vol 33, Num 10, pp 1070-1077, issn 0363-9045, 8 p.Article
Optimization of propranolol hydrochloride sustained-release pellets using Box-Behnken design and desirability functionBODEA, A; LEUCUTA, S. E.Drug development and industrial pharmacy. 1998, Vol 24, Num 2, pp 145-155, issn 0363-9045Article
Optimization of propranolol hydrochloride sustained release pellets using a factorial designBODEA, A; LEUCUTA, S. E.International journal of pharmaceutics. 1997, Vol 154, Num 1, pp 49-57, issn 0378-5173Article
Optimization of hydrophilic matrix tablets using a D-optimal designBODEA, A; LEUCUTA, S. E.International journal of pharmaceutics. 1997, Vol 153, Num 2, pp 247-255, issn 0378-5173Article
ESTIMATION OF DIAZEPAM BIOAVAILABILITY FROM TABLETS BY THE MEASUREMENT OF ITS CLINICAL EFFECTPOP R; MOLDOVAN O; FODOREANU L et al.1980; DRUGS EXPER. CLIN. RES.; CHE; DA. 1980; VOL. 6; NO 1; PP. 45-52; BIBL. 4 REF.Article
Preparation, in vitro release and skin absorption of hydrocortisone acetate from a liposome gelMOLDOVAN, M; LEUCUTA, S. E; BAKRI, A et al.Journal of drug delivery science and technology. 2006, Vol 16, Num 2, pp 127-132, 6 p.Article
Dynamic swelling behaviour of gelatin/poly(acrylic acid) bioadhesive microspheres loaded with oxprenololLEUCUTA, S. E; PONCHEL, G; DUCHENE, D et al.Journal of microencapsulation. 1997, Vol 14, Num 4, pp 501-510, issn 0265-2048Article
PHARMACOKINETICS AND BIOAVAILABILITY OF LITHIUM ADMINISTERED TO DOGS AS MONOGLUTAMATE AND CARBONATELEUCUTA S; POP R; KORY M et al.1979; PHARM. ACTA HELV.; CHE; DA. 1979; VOL. 54; NO 11; PP. 343-346; BIBL. 10 REF.Article
HERSTELLUNG VON FILMBILDENDEN PRAEPARATEN MIT WIRKUNG GEGEN AKNE = L'OBTENTION DE PREPARATION FORMANT UN FILM, AVEC UNE ACTIVITE CONTRE L'ACNEBAN I; LEUCUTA S; POLINICENCU C et al.1974; PHARMAZIE; DTSCH.; DA. 1974; VOL. 29; NO 9; PP. 597-602; BIBL. 27REF.Article
Oxprenolol release from bioadhesive gelatin/poly(acrylic acid) microspheresLEUCUTA, S. E; PONCHEL, G; DUCHENE, D et al.Journal of microencapsulation. 1997, Vol 14, Num 4, pp 511-522, issn 0265-2048Article
Preparation and pharmaceutical/pharmacokinetic characterization of liposomes and nanoparticles loaded with epirubicinLEUCUTA, S. E; ACHIM, M; RISCA, R et al.STP pharma sciences. 2003, Vol 13, Num 5, pp 291-297, issn 1157-1489, 7 p.Article
Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental designTOMUTA, I; ALECU, C; RUS, L. L et al.Drug development and industrial pharmacy. 2009, Vol 35, Num 9, pp 1072-1081, issn 0363-9045, 10 p.Article
Gelatin microspheres containing epirubicin: pharmaceutical, pharmacokinetic and antitumour effect characterizationACHIM, M; RISCA, R; DAICOVICIU, D et al.STP pharma sciences. 2002, Vol 12, Num 5, pp 275-282, issn 1157-1489, 8 p.Article
Determination of phenolic compounds from Geranium sanguineum by HPLCLEUCUTA, S; VLASE, L; GOCAN, S et al.Journal of liquid chromatography & related technologies. 2005, Vol 28, Num 19, pp 3109-3117, issn 1082-6076, 9 p.Article
Albumin microspheres as a drug delivery system for epirubicin: pharmaceutical, pharmacokinetic and biological aspectsLEUCUTA, S. E; RISCA, R; DAICOVICIU, D et al.International journal of pharmaceutics. 1988, Vol 41, Num 3, pp 213-217, issn 0378-5173Article
Relative bioavailability of different oral sustained release oxprenolol tabletsLEUCUTA, S. E; FOLLIDIS, M; CAPALNEANU, R et al.European journal of drug metabolism and pharmacokinetics. 1998, Vol 23, Num 2, pp 178-184, issn 0378-7966Conference Paper
Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteersVLASE, L; NEAG, M; POPA, A et al.Journal of clinical pharmacy and therapeutics (Print). 2011, Vol 36, Num 2, pp 225-229, issn 0269-4727, 5 p.Article
Paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres : preparation and in vitro evaluationACHIM, M; TOMUTA, I; VLASE, L et al.Journal of drug delivery science and technology. 2008, Vol 18, Num 6, pp 410-416, issn 1773-2247, 7 p.Article